DE60028575D1 - Peptiden reich an Cystein und/oder Glycin - Google Patents

Peptiden reich an Cystein und/oder Glycin

Info

Publication number
DE60028575D1
DE60028575D1 DE60028575T DE60028575T DE60028575D1 DE 60028575 D1 DE60028575 D1 DE 60028575D1 DE 60028575 T DE60028575 T DE 60028575T DE 60028575 T DE60028575 T DE 60028575T DE 60028575 D1 DE60028575 D1 DE 60028575D1
Authority
DE
Germany
Prior art keywords
cysteine
peptides
glycine
preparation
protein source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60028575T
Other languages
English (en)
Other versions
DE60028575T2 (de
Inventor
Leon Franciscus Mallee
Ram Nimmagudda
Johannes Wilhelmus Leo Boumans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Campina Melkune BV
Original Assignee
Campina Melkune BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Campina Melkune BV filed Critical Campina Melkune BV
Application granted granted Critical
Publication of DE60028575D1 publication Critical patent/DE60028575D1/de
Publication of DE60028575T2 publication Critical patent/DE60028575T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/833—Whey; cheese

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60028575T 2000-10-24 2000-10-24 Peptiden reich an Cystein und/oder Glycin Expired - Lifetime DE60028575T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00203699A EP1201137B1 (de) 2000-10-24 2000-10-24 Peptiden reich an Cystein und/oder Glycin

Publications (2)

Publication Number Publication Date
DE60028575D1 true DE60028575D1 (de) 2006-07-20
DE60028575T2 DE60028575T2 (de) 2007-06-28

Family

ID=8172176

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028575T Expired - Lifetime DE60028575T2 (de) 2000-10-24 2000-10-24 Peptiden reich an Cystein und/oder Glycin

Country Status (9)

Country Link
US (1) US6620778B2 (de)
EP (1) EP1201137B1 (de)
JP (2) JP4293745B2 (de)
AT (1) ATE328491T1 (de)
AU (1) AU783732B2 (de)
CA (1) CA2359606A1 (de)
DE (1) DE60028575T2 (de)
DK (1) DK1201137T3 (de)
NZ (1) NZ515005A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224096A1 (en) * 2002-06-04 2003-12-04 Novozymes A/S Whey protein hydrolysate
BR0312537A (pt) 2002-07-01 2005-04-19 Unilever Nv Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta
US6787168B1 (en) * 2003-03-18 2004-09-07 James W. Sawhill Peptide product
GB2403475B (en) * 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
AR047658A1 (es) 2004-02-03 2006-02-01 Cargill Inc Concentrado de proteinas y corriente acuosa con carbohidratos hidrosolubles
JP2007522208A (ja) * 2004-02-12 2007-08-09 キャンピナ・ネダーランド・ホールディング・ビー．ブイ． チオールのホメオスタシスを改良するためのシステインリッチのペプチド
EP1723951A1 (de) 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
ATE542896T1 (de) 2004-12-23 2012-02-15 Campina Nederland Holding Bv Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20080199512A1 (en) * 2005-09-02 2008-08-21 Steffi Dudek Oral Composition For Moisturizing Skin
EP1954299B1 (de) * 2005-11-30 2016-01-13 Campina Nederland Holding B.V. Verwendung eines proteinhydrolysates zur erhöhung der aktivität des glp-1
US8637325B2 (en) * 2009-02-16 2014-01-28 University Of Wyoming Method and apparatus for pyrolysis-induced cleavage in peptides and proteins
US20100069288A1 (en) * 2008-09-12 2010-03-18 Wulf Droge Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
WO2010147456A1 (en) 2009-06-19 2010-12-23 N.V. Nutricia Inhibition of nfk-b mediated virus replication with specific oligosaccharides
NL2006807C2 (en) 2011-01-31 2012-08-01 Primeval B V Nutritional composition for equine reproductive health.
WO2012138213A1 (en) 2011-04-08 2012-10-11 N.V. Nutricia Reduction of vascular dysfunction with specific saccharides
CN103005142B (zh) * 2012-12-13 2014-01-15 内蒙古伊利实业集团股份有限公司 α-乳白蛋白水解物及其制备方法与应用
CN103146791A (zh) * 2013-03-13 2013-06-12 扬州大学 多种蛋白酶水解蛋清蛋白的方法
EP4138771B1 (de) * 2020-04-20 2024-03-06 Evonik Operations GmbH Zusammensetzungen mit cys-peptiden

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
US5464825A (en) * 1991-03-14 1995-11-07 Cornell Research Foundation, Inc. Raising glutathione equivalent levels using N-acyl glutathione monoesters
DE4130284A1 (de) 1991-09-12 1993-03-18 Willi Prof Dr Med Habil Heine Verfahren zur herstellung biologisch hochwertiger nahrungseiweisse
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
JP3979543B2 (ja) 1994-01-31 2007-09-19 雪印乳業株式会社 抗アレルギー剤及びその製造法
FR2758330B1 (fr) * 1997-01-10 1999-03-26 Roquette Freres Composition azotee resultant de l'hydrolyse du gluten de ble et son procede de fabrication
AU6948198A (en) * 1997-04-04 1998-10-30 Monsanto Company High beta-conglycinin products and their use

Also Published As

Publication number Publication date
JP4293745B2 (ja) 2009-07-08
EP1201137A1 (de) 2002-05-02
NZ515005A (en) 2003-07-25
CA2359606A1 (en) 2002-04-24
DK1201137T3 (da) 2006-07-17
JP2009112312A (ja) 2009-05-28
JP2003033197A (ja) 2003-02-04
DE60028575T2 (de) 2007-06-28
US6620778B2 (en) 2003-09-16
EP1201137B1 (de) 2006-06-07
US20020090670A1 (en) 2002-07-11
JP4348402B2 (ja) 2009-10-21
ATE328491T1 (de) 2006-06-15
AU8156701A (en) 2002-05-02
AU783732B2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
DE60028575D1 (de) Peptiden reich an Cystein und/oder Glycin
EA200400632A1 (ru) Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
WO2003008443A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
EA199901025A1 (ru) Пептидные аналоги паратиреоидного гормона
WO2002048183A3 (en) Compositions of peptide crystals
DE60143234D1 (de) Peptid
WO2003057881A1 (fr) Procede de stabilisation d'une proteine
AR012010A1 (es) Metodo para el procesamiento de una solucion acuosa de proteina c activada
AU5989499A (en) Method for prevention and/or cosmetic treatment of skin striae and use in dermatology
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
DE50004018D1 (de) Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
DK1223990T3 (da) Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
IL172844A0 (en) Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
ATE497390T1 (de) Neue therapeutische verwendung von smr-1 peptide
EA200600128A1 (ru) Способ уничтожения раковых клеток (варианты), фармацевтическое средство (варианты) и набор для его осуществления
DK1339735T3 (da) Fremgangsmåde til fremstilling af tryptophanrige peptider
EP1374887A4 (de) Neue mittel zur linderung von motorischen störungen
MXPA03006266A (es) Uso de l-carnitina como agente estabilizador de proteinas.
SE9904132D0 (sv) Pharmaceutical composition for treatment of diarrhea
EP1714979A3 (de) Peptide für die Behandlung von Tumoren und anderen Zuständen, die das entfernen oder zerstören von Zellen erfordern
DE60044468D1 (de) Herstellung von sekretierten polypeptiden
DE60217302D1 (de) Erhaltung von körpereigenen proteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition